Pharmacy
Diagnostic tests on urine, blood often cost less than a trip to the movies, as California-based startup aims to take over the market.
Entrepreneur claims direct-to-consumer laboratory testing and price transparency are an integral piece of health reform and a solution to America's disease and cost problems.
Expenses are climbing by 8 percent this year over last, from $416 billion in 2014 to $608 billion in 2015, according to a new report from Kalorama Information.
Depending on how much the program is reformed, it could mean the difference of hundreds of millions of dollars for the thousands of hospitals who get a drug discount.
The top M&A in the sector have already totaled more than $64 billion, according to the Healthcare M&A Information Source by Irving Levin Associates.
Actavis said the newly combined company, which will take on the Allergan name, is expected to net $23 billion in sales in 2015.
Shares of Farmingdale, New York-based Enzo Biochem fell as low as 17 percent on Tuesday after a federal appeals court threw out a patent infringement ruling it won against Applera.
Allergen said it will use the money to fund its upcoming clinical trial of a treatment that uses peanut protein to treat people with peanut allergies.
Walgreens said it is cutting ties with two accountable care organizations, though the nation's largest pharmacy chain has also launched a new partnership on the West Coast to help manage ACO patients.
The third largest U.S. retail company is partnering with a well-known integrated delivery system to evolve the primary care walk-in clinic, in a confident bet on retail health.